Olivier Preynat-Seauve Laboratory of Experimental cell therapy, Department of Diagnostics Geneva University Hospitals Biography Publications Institution JoVE Articles Olivier Preynat-Seauve has not added a biography. If you are Olivier Preynat-Seauve and would like to personalize this page please email our Author Liaison for assistance. Publications Viral Metagenomics of Blood Donors and Blood-Derived Products Using Next-Generation Sequencing Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. Apr, 2019 | Pubmed ID: 31191194 Cell-free Nucleic Acids Are Present in Blood Products and Regulate Genes of Innate Immune Response Transfusion. 07, 2018 | Pubmed ID: 29664127 Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma Cancer Cell. Dec, 2017 | Pubmed ID: 29198914 Comprehensive Metagenomic Analysis of Glioblastoma Reveals Absence of Known Virus Despite Antiviral-like Type I Interferon Gene Response International Journal of Cancer. Sep, 2014 | Pubmed ID: 24347514 A Key Role for NOX4 in Epithelial Cell Death During Development of Lung Fibrosis Antioxidants & Redox Signaling. Aug, 2011 | Pubmed ID: 21391892 Pluripotent Stem Cells As New Drugs? The Example of Parkinson's Disease International Journal of Pharmaceutics. Nov, 2009 | Pubmed ID: 19782880 Organoïdes neuronaux humains pour étudier le cancer du cerveau et les maladies neurodégénératives Erika Cosset*1, Manon Locatelli*2, Antoine Marteyn2, Pierre Lescuyer3, Florence Dall Antonia3, Flavio Maurizio Mor4, Olivier Preynat-Seauve5, Luc Stoppini4, Vannary Tieng2 1Laboratory of Tumor Immunology, Translational Research Center in Onco-Hematology, Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, 2Department of Pathology and Immunology, University Medical Center, University of Geneva, 3Laboratory of Toxicology and Therapeutic Drug Monitoring, Geneva University Hospitals, 4Tissue Engineering Laboratory, Hepia/HES-SO, University of Applied Sciences Western Switzerland, 5Laboratory of Experimental cell therapy, Department of Diagnostics, Geneva University Hospitals JoVE 59682 Bioengineering
Organoïdes neuronaux humains pour étudier le cancer du cerveau et les maladies neurodégénératives Erika Cosset*1, Manon Locatelli*2, Antoine Marteyn2, Pierre Lescuyer3, Florence Dall Antonia3, Flavio Maurizio Mor4, Olivier Preynat-Seauve5, Luc Stoppini4, Vannary Tieng2 1Laboratory of Tumor Immunology, Translational Research Center in Onco-Hematology, Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, 2Department of Pathology and Immunology, University Medical Center, University of Geneva, 3Laboratory of Toxicology and Therapeutic Drug Monitoring, Geneva University Hospitals, 4Tissue Engineering Laboratory, Hepia/HES-SO, University of Applied Sciences Western Switzerland, 5Laboratory of Experimental cell therapy, Department of Diagnostics, Geneva University Hospitals JoVE 59682 Bioengineering
